Form 4: MIND Director Hilarides Granted 30,000 Stock Options
Insider Transaction Report
MIND TECHNOLOGY, INC. Director William Hunter Hilarides was granted 30,000 options to purchase common stock with an exercise price of $8.64, vesting over three years.
Summary
- William Hunter Hilarides, a Director of MIND TECHNOLOGY, INC. (MIND), acquired 30,000 options to purchase common stock.
- The options have an exercise price of $8.64 per share.
- The grant date for these options was October 6, 2025.
- The options will vest in three equal annual installments: 1/3 on October 6, 2026, 1/3 on October 6, 2027, and the final 1/3 on October 6, 2028.
- The expiration date for these options is October 6, 2035.
- Following this transaction, Mr. Hilarides directly beneficially owns 30,000 derivative securities.
Sentiment
Score: 6
Explanation: The grant of stock options to a director is generally a neutral to slightly positive event, as it aligns management's interests with shareholders through equity ownership, without directly impacting current financial performance or operations.
Positives
- The grant of stock options to a director increases their equity stake in the company, aligning their interests with those of shareholders.
- The long-term vesting schedule encourages sustained commitment and performance from the director over several years.
Future Outlook
The filing details a future vesting schedule for the granted options, indicating that the director's equity stake will increase incrementally over the next three years, contingent on continued service.
Industry Context
This filing is a standard disclosure of an insider equity transaction, common across all industries for publicly traded companies, reflecting a component of executive and director compensation.
Stakeholder Impact
- Shareholders: The grant of options to a director can be viewed positively as it increases the director's personal stake in the company's long-term performance, potentially fostering greater alignment with shareholder interests.
Next Steps
- The options will vest in three annual installments on October 6, 2026, October 6, 2027, and October 6, 2028.
Key Dates
| Date | Description |
|---|---|
| 10/06/2025 | Date of option grant and earliest transaction date. |
| 10/08/2025 | Date the Form 4 was signed and filed. |
| 10/06/2026 | First vesting date for 1/3 of the options. |
| 10/06/2027 | Second vesting date for 1/3 of the options. |
| 10/06/2028 | Third and final vesting date for 1/3 of the options. |
| 10/06/2035 | Expiration date of the options. |
Keywords
MIND TECHNOLOGY, MIND, Stock Options, Insider Transaction, Director Compensation, Equity Grant, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.